secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001213900-25-098131
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharma shareholders approve reverse split, equity plan amendment at annual meeting
--------------------------------------------------------------------------------

- Five directors elected: Geoffrey Dow, Charles Allen, Cheryl Xu, Stephen Toovey, Paul Field.
- Amendment to 2022 Equity Incentive Plan approved, increasing available shares by 250,000.
- Reverse stock split authorized at ratio ranging from 1:3 to 1:10, as determined by the Board.
- Ratification of RBSM LLP as independent registered public accounting firm for FY2025.
- Adjournment proposal approved; quorum of ~40% of outstanding shares was present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025098131/0001213900-25-098131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025098131/ea0260878-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-098131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer